Carol E. Koro

4.3k citations

56 papers · 3.3k indexed · 2 hit papers · h-index 25

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
Psychiatry and Mental health top 2%
- Schizophrenia research and treatment

Papers in

Endocrinology, Diabetes and Metabolism 28
- Diabetes Treatment and Management 21
- Diabetes, Cardiovascular Risks, and Lipoproteins 14
- Diabetes Management and Research 10
Nephrology 4
- Chronic Kidney Disease and Diabetes 4

Co-authors: Donald O. Fedder Gregory A. Nichols Steven J. Bowlin Jonathan M. Meyer Jonathan B. Brown Sara A. Ephross Christina M. Gullion Gilbert L’Italien
Journals: Pharmacoepidemiology and Drug Safety (7 papers)Clinical Therapeutics (7 papers)Diabetes & Metabolic Syndrome Clinical Research & Reviews (5 papers)Diabetes Care (3 papers)Contraception (3 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Carol E. Koro

53 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

The Incidence of Congestive Heart Failure in Type 2 Diabetes 2004 · 580 citations

Peers

Countries citing papers authored by Carol E. Koro

Since Specialization

Citations

This map shows the geographic impact of Carol E. Koro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol E. Koro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol E. Koro more than expected).

Fields of papers citing papers by Carol E. Koro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol E. Koro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol E. Koro. The network helps show where Carol E. Koro may publish in the future.

Co-authors

The 25 scholars most cited alongside Carol E. Koro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carol E. Koro Line = papers co-authored together Carol E. Koro links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High coverage and adherence to dose intervals of the national school-based HPV vaccination program in Sweden during 2012–2019 Preventive Medicine Reports ·Jiangrong Wang, Eva Herweijer, Sara Nordqvist Kleppe, Susanne Hartwig, Christine Velicer, Carol E. Koro, Karin Sundström	2023	5
2	Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review Expert Review of Vaccines ·Wei Wang, Smita Kothari, Jozica Skufca, Anna R. Giuliano, Karin Sundström, Mari Nygård, Carol E. Koro, Marc Baay, Thomas Verstraeten, Alain Luxembourg, Alfred J. Saah, Suzanne M. Garland	2022	33
3	SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study Diabetes Therapy ·Tongtong Wang, Shrita M. Patel, Anne Hickman, Xinyue Liu, NashwaS Ghanem, Ira Gantz, Carol E. Koro	2020	23
4	Knowledge and Understanding of the Safety and Efficacy Aspects of BRIDION® Among Canadian Anesthesiologists Drugs - Real World Outcomes ·Annette Stemhagen, Kim J. Dilley, Wenjun Zhong, H Al Agram, Xin Zhuo, Carol E. Koro	2020	1
5	Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study Atherosclerosis ·Annette L. Fitzpatrick, Michael C. Irizarry, Mary Cushman, Nancy S. Jenny, C. Gloria, Carol E. Koro	2014	35
6	Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: A systematic review of the literature Atherosclerosis ·John Gregson, Heide A. Stirnadel-Farrant, فايق عوضين, Carol E. Koro	2012	24
7	Kidney Function Decline in the Elderly: Impact of Lipoprotein-Associated Phospholipase A<sub>2</sub> American Journal of Nephrology ·Carmen A. Peralta, Ronit Katz, Michael G. Shlipak, Ruth F. Dubin, Ian DeBoer, Nancy S. Jenny, Annette L. Fitzpatrick, Carol E. Koro, Bryan Kestenbaum, Joachim H. Ix, Mark J. Sarnak, Mary Cushman	2011	7
8	Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States Clinical Therapeutics ·Carol E. Koro, B. Leighton, Reinhard Efraim Murbijanto	2009	105
9	The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: A retrospective cohort study using a US health insurance database Clinical Therapeutics ·Najat J. Ziyadeh, Andrew T. McAfee, Carol E. Koro, Joan Landon, K. Arnold Chan	2009	32
10	An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients Pharmacoepidemiology and Drug Safety ·Carol E. Koro, Qinggong Fu, Monika Stender	2008	13
11	The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: A nested case-control analysis Clinical Therapeutics ·Carol E. Koro, C.A. Harwood, Monika Stender, Nawab Qizilbash	2008	5
12	Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000–2007 Pharmacoepidemiology and Drug Safety ·Alexander M. Walker, Carol E. Koro, Joan Landon	2008	29
13	The incidence of heart failure among nondiabetic patients with and without impaired fasting glucose Journal of Diabetes and its Complications ·Gregory A. Nichols, Carol E. Koro, Nikheel S. Kolatkar	2008	9
14	Does Statin Therapy Initiation Increase the Risk for Myopathy? An Observational Study of 32,225 Diabetic and Nondiabetic Patients Clinical Therapeutics ·Gregory A. Nichols, Carol E. Koro	2007	137
15	The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: A retrospective chart review involving up to 8 years of follow-up Clinical Therapeutics ·Gregory A. Nichols, Carol E. Koro, R Olasiman, Steven J. Bowlin, Dennis L. Sprecher	2006	6
16	Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication Pharmacoepidemiology and Drug Safety ·Carol E. Koro, Steven J. Bowlin, Sheila R. Weiss	2005	22
17	Major CHD risk factors predominate among African-American women who are eligible for lipid-lowering drug therapy under the new ATP III guidelines European Journal of Cardiovascular Prevention & Rehabilitation ·Carol E. Koro, Gilbert L’Italien, Donald O. Fedder	2004	4
18	The effects of antipsychotic therapy on serum lipids: a comprehensive review Schizophrenia Research ·Jonathan M. Meyer, Carol E. Koro	2004	313
19	The incidence of congestive heart failure associated with antidiabetic therapies Diabetes/Metabolism Research and Reviews ·Gregory A. Nichols, Carol E. Koro, Christina M. Gullion, Sara A. Ephross, Jonathan B. Brown	2004	78
20	Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study BMJ ·Carol E. Koro, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2002	299

About Carol E. Koro

Carol E. Koro is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Internal Medicine, Cardiology and Cardiovascular Medicine and Geriatrics and Gerontology, having authored 56 papers that have together received 3.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (21 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers), Lipoproteins and Cardiovascular Health (13 papers), Diabetes Management and Research (10 papers), Cardiovascular Function and Risk Factors (7 papers), Metabolism, Diabetes, and Cancer (6 papers), Schizophrenia research and treatment (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.8k citations), Psychiatry and Mental health (706 citations), Cardiology and Cardiovascular Medicine (684 citations), Family Practice (50 citations) and Geriatrics and Gerontology (73 citations). Carol E. Koro has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Donald O. Fedder, Gregory A. Nichols, Steven J. Bowlin, Jonathan M. Meyer, Jonathan B. Brown, Sara A. Ephross, Christina M. Gullion, Gilbert L’Italien, Joan Landon and Nawab Qizilbash. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Clinical Therapeutics, Diabetes & Metabolic Syndrome Clinical Research & Reviews, Diabetes Care and Contraception.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact